Two algae and two plant fibers sold to clear stored lead, mercury, cadmium and arsenic. The binding chemistry is real, but human evidence that swallowing them lowers stored metal is thin — small studies without comparison groups, most funded by the seller. Testing keeps finding lead in these products; product choice and dose timing can remove most of the hazard. (Full Review)

Protocol

Modified citrus pectin dosing

4.5 g/day

2:1 ratio with sodium alginate, in divided doses; excretion studies used 15–20 g/day of powder

Chlorella dosing

6–10 g/day

Added separately from the fiber binder; spirulina 1–8 g/day; broken-cell-wall form used in studies

Timing and time of day

Empty stomach, split into 2–3 doses

Fiber binders 30–60 minutes before meals or 2 hours after, one dose commonly at bedtime; algae with food

Time to effect

Symptomatic change

16 weeks

Skin lesion improvement in the arsenic trial, where it occurred at all

Body burden

Weeks to months

Falling blood or hair levels; 2–4 weeks in the pediatric lead study, up to 7 months in the case series

Metal output

1–6 days

Urinary or fecal output, reflecting binding of what is already in transit

Benefits

High: Improved blood lipid profile

Medium: Reduced skin lesions and increased arsenic clearance in chronic arsenic exposure; enhanced antioxidant defense and reduced oxidative stress; reduced gastrointestinal absorption of ingested metals and metal analogues; lower blood pressure; reduced allergic rhinitis symptoms; improved fasting glucose and insulin concentrations; reduced reflux and heartburn symptoms; reduced body weight and body fat in overweight adults

Low: Improved liver enzymes and liver fat in fatty liver disease; improved aerobic exercise capacity; increased urinary excretion of toxic elements; reduced body burden of multiple metals; lower dioxin transfer into breast milk; improved iron status and red blood cell indices

Speculative: Increased fecal excretion of uranium; interruption of enterohepatic recirculation of methylmercury in humans; galectin-3 antagonism

Contraindications

Phenylketonuria (absolute)

Active systemic lupus erythematosus, dermatomyositis, pemphigus or Graves disease (algae components)

Solid organ transplant recipients on immunosuppression (algae components)

Pregnancy and breastfeeding without batch-level heavy metal and cyanotoxin certification

Systemically absorbed chelating agents in chronic kidney disease stage 4 or worse (filtration rate below 30 mL/min/1.73 m²) without nephrology supervision

Documented allergy to algae, seaweed, mold or citrus

Dysphagia or a history of esophageal stricture (gel-forming powders)

Serum uric acid above 7 mg/dL or a history of gout (limit algae intake)

Key Interactions

Vitamin K antagonists (warfarin, phenprocoumon)

Levothyroxine and thyroid hormone preparations

Tetracyclines and quinolones (doxycycline, ciprofloxacin)

Bisphosphonates (alendronate) and oral iron salts

Immunosuppressants and biologics (tacrolimus, methotrexate)

Analgesics and antiplatelet agents (aspirin, clopidogrel)

Antacids and acid suppressants (calcium carbonate, omeprazole)

Digoxin, lithium, phenytoin and other narrow-therapeutic-index oral medications

CYP1A2 and CYP2E1 substrates (theophylline, acetaminophen)

Antihypertensives (amlodipine, lisinopril)

Antidiabetics (insulin, sulfonylureas, metformin)

Iodine-containing agents (amiodarone, kelp)

Other metal-binding or laxative supplements (activated charcoal, cholestyramine)

Antioxidant or immunostimulatory supplements (N-acetylcysteine, echinacea)

Blood-pressure- or glucose-lowering supplements (beetroot, berberine)

Risk & Side Effects

High: Gastrointestinal symptoms; contamination of the products themselves with toxic metals

Medium: Cyanotoxin contamination of spirulina; allergic reactions including anaphylaxis; reduced absorption of co-administered drugs and nutrients; immune stimulation and autoimmune flares

Low: Photosensitivity from chlorella; iodine excess from alginate-containing formulas; sodium load from the alginate component; interference with vitamin K antagonist anticoagulation; purine and phenylalanine load; inactive vitamin B12 analogues in spirulina; additive blood pressure and blood sugar lowering; liver injury and muscle breakdown

Speculative: Mineral depletion; increased bleeding tendency; redistribution of mobilized metals to the brain

Monitoring

Marker	Target	Why
Whole blood lead	< 1 µg/dL	Reflects recent exposure and the mobilizable pool
Whole blood or urine cadmium	Blood < 0.3 µg/L; urine < 0.5 µg/g creatinine	Recent intake, plus accumulated kidney burden
Whole blood mercury with speciation	< 2 µg/L total	Separates fish methylmercury from inorganic mercury
Urine arsenic, speciated	Inorganic plus methylated species < 15 µg/g creatinine	Only inorganic and methylated forms are relevant
Serum ferritin with transferrin saturation	Ferritin 50–150 ng/mL; saturation 25–35 %	Iron deficiency raises lead and cadmium absorption
Serum zinc and plasma selenium	Zinc 90–110 µg/dL; selenium 125–150 µg/L	Compete with toxic metals; support antioxidant enzymes
Estimated glomerular filtration rate with cystatin C	> 90 mL/min/1.73 m²	Defines the urinary route; detects cadmium kidney injury
Urine beta-2 microglobulin or retinol-binding protein	Within laboratory reference range	Earliest marker of cadmium proximal tubule damage
Thyroid stimulating hormone with free thyroxine	Thyroid stimulating hormone 0.5–2.0 mIU/L	Detects iodine excess from alginate and thyroid disruption
Alanine aminotransferase with gamma-glutamyl transferase	Alanine aminotransferase < 25 U/L in men and < 20 U/L in women	Detects microcystin liver injury; tracks biliary excretion
Serum uric acid	3.5–5.5 mg/dL	Nucleic acid load of both algae raises urate

Cadence: Baseline before the first dose, unprovoked specimens only; metal panel and kidney function at 8–12 weeks, with thyroid stimulating hormone where alginate is used; full panel every 6 months; final panel 3 months after stopping

Qualitative Assessment

Energy levels and exercise tolerance, weekly on a 1–10 scale
Cognitive clarity, concentration and short-term recall
Sleep quality and time to fall asleep
Stool frequency, form and comfort
Skin appearance, particularly any new sun-exposed rash
Headache, metallic taste or malaise after a dose increase

Spirulina, Chlorella, MCP & Modified Alginate Complex for Heavy Metal Detoxification

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment